Screener / SEC EDGAR /CIK 0001030894 /10-K filed Feb 27, 2026, compared with Mar 3, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Technology · Electronic Components

Celestica Inc CLS

Compare with peers Embed
SEC comment letters, last 20 years

7 reviews of CLS's filings by SEC staff

UPLOAD and CORRESP
Reviews 7 latest letter Jul 13, 2022
Questions asked 47 each answered in the company's own letter
No closing letter 2 reviews without a letter saying the staff completed it

When the SEC's staff reviews a filing, it writes to the company with numbered questions, and the company answers each one in a letter. SEC publishes the exchange once the review is over, at least 20 business days later. A question is not an accusation; most reviews end with the company adding detail to its next filing.

How the reviews went

Every review on EDGAR, from the first staff letter to the letter that closes it

  1. 1. Staff letters 10 UPLOAD
  2. 2. Questions in them 47 numbered comments
  3. 3. Company replies 10 CORRESP
  4. 4. Reviews closed 5 of 7 closing letter

Half the closed reviews took 47 days or less from the first letter to the closing letter.

Form 20-F for the Fiscal Year Ended December 31, 2021

2022-07-13 to 2022-08-22 · 5 questions · 1 letter from the SEC, 1 from the company
Review closed 2022-08-22
Results discussion (MD&A)Non-GAAP measuresRevenueIncome taxesLiquidity and cash
Management's Discussion and Analysis of Financial Condition and Results of Operations · Non-IFRS Financial Measures, page 87
SEC asked (1)
In the fourth paragraph you refer to operating earnings and operating margin. In future filings, please refer to these measures as “non-IFRS operating earnings” and “non-IFRS operating margin” to be consistent with your table on page 89 and avoid confusion by a reader.
CLS answered
We now (and in future filings will continue to) refer to operating earnings and operating margin as “non-IFRS operating earnings” and “non-IFRS operating margin,” respectively.
Read in the reply
Management's Discussion and Analysis of Financial Condition and Results of Operations · Non-IFRS Financial Measures, page 87
SEC asked (2)
We note that your measure, non-IFRS operating earnings, is reconciled to IFRS earnings before income taxes. In this regard, please revise future filings, to reconcile non-IFRS operating earnings to earnings from operations, the most directly comparable IFRS measure. Refer to Item 10(e)(1)(i)(B) of Regulation S-K.
CLS answered
We now (and in future filings will continue to) reconcile non-IFRS operating earnings to earnings from operations.
Read in the reply
Management's Discussion and Analysis of Financial Condition and Results of Operations · Non-IFRS Financial Measures, page 87
SEC asked (3)
Your calculation of free cash flow differs from the typical calculation of this measure (i.e., cash flows from operations less capital expenditures). In future filings, in order to avoid potential confusion, please revise the title of your non-IFRS measure to “adjusted free cash flow” or a similar title. Refer to Question 102.07 of the Compliance & Disclosure Interpretations on Non-GAAP Financial Measures.
Rest of the question

Notes to the Consolidated Financial Statements 2. Basis of Preparation and Significant Accounting Policies (r) Revenue and deferred investment costs, page F-21

CLS answered
We now (and in future filings will continue to) refer to our non-IFRS free cash flow measure as “adjusted free cash flow.”

Notes to the Consolidated Financial Statements

2. Basis of Preparation and Significant Accounting Policies

(r) Revenue and deferred investment costs, page F-21
Read in the reply
Management's Discussion and Analysis of Financial Condition and Results of Operations · Non-IFRS Financial Measures, page 87
SEC asked (4)
Please tell us what consideration you have given to disaggregated revenue disclosures by business line/end user (e.g., Aerospace & Defense, Capital Equipment, Communications). Refer to IFRS 15.114.
CLS answered
We respectfully acknowledge the Staff’s comment, and recognize that IFRS 15.114 requires an entity to disaggregate revenue recognized from contracts with customers into categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors, by applying the guidance in paragraphs 114 and B87-89 of IFRS 15 when selecting the categories to use.
Rest of the answer

We have considered the requirements and guidance set forth in IFRS 15.114 and IFRS 15.B87-89, and have determined that our current disaggregation of revenue by two distinct revenue streams (as described below) is appropriate and sufficient for readers of our financial statements, and that further disaggregation by business or product line/end user is not required by those sections.

We offer a comprehensive range of product manufacturing, supply chain management and other related services to customers in a wide range of industries. Based on the criteria in IFRS 15.114 and relevant guidance, we have divided our portfolio of contracts for purposes of financial statement disaggregated revenue disclosure into two separate revenue streams, consisting of our Advanced Technology Solutions (ATS) revenue stream and our Connectivity & Cloud Solutions (CCS) revenue stream. As is explained in more detail below, although our ATS revenue stream and CCS revenue stream are comprised of customers operating in a variety of industries (including, among others, Aerospace and Defense, Capital Equipment and Communications), we have determined that as a result of the similarity of the contract terms, profitability profile, working capital requirements and product life cycle of the product lines within each revenue stream, presenting a further revenue breakdown would not provide a more meaningful depiction of how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.

Our ATS revenue contracts

(regardless of product line/end user) have common characteristics (described below). Based on those common characteristics, we believe that presenting further disaggregation of revenues beyond what is presented in the financial statements (i.e., by specific product line/end user) would not provide a more meaningful depiction of how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. The revenue contracts within our ATS revenue stream, irrespective of the customer’s industry, are typically based on highly specialized complex manufacturing processes that take a longer period of time to complete than our other contract revenues. Given the generally complex manufacturing processes characteristic of the products and services that comprise our ATS revenue contracts, we are required to make significant investments in working capital, project planning and design. In addition, as a result of the longer-term and more rigid nature of ATS manufacturing processes, the

ATS revenue stream (again, regardless of product line/end user) is generally less able to quickly react to applicable changes in the economic environment, and is therefore subject to higher margin volatility. However, the product lines within this revenue stream are also expected to result in comparatively higher margins due to the investment levels required to satisfy relevant performance criteria. Other considerations in our determination not to further disaggregate our ATS revenue contracts in our financial statements include that the nature of their products/services typically result in lower volumes and higher prices than our other contract revenues, and that our ATS revenue stream customers operate in industries that are generally subject to relatively greater government regulation (notwithstanding the various industries in which our ATS customers operate).

Contracts in our CCS revenue stream

(regardless of product line/end user) also share certain characteristics. As with our ATS revenue steam analysis, based on those common characteristics, we believe that presenting further disaggregation of revenues beyond what is presented in the financial statements (i.e., by specific product line/end user) would not provide a more meaningful depiction of how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. Specifically, in contrast to our

ATS revenue contracts, our CCS revenue contracts generally have lower margin profiles and are more sensitive to negative pricing pressures (as they serve customers operating in economic environments that are highly competitive and subject to rapid technology-driven changes in demand), a higher comparative degree of volatility in product mix, shorter and less complex manufacturing processes, and lower working capital requirements (regardless of the industry in which the end customer operates).

Given the less complex manufacturing processes and increased susceptibility to pricing pressures and technology changes, contracts within the CCS revenue stream are also typically characterized by comparatively higher volumes and lower prices.

In assessing the guidance set forth in

IFRS 15.B89 (described below), and based on the foregoing description of our revenue streams, we determined that specific product lines or end users would not be an appropriate basis for revenue disaggregation in our financial statements, as we believe that the impact of economic factors on the product lines/end users within each revenue stream would be generally comparable. For example, in economic environments with rising interest rates, our customers (regardless of type or product line) are generally impacted similarly in terms of pressures on their working capital requirements (e.g., with respect to deposits or required consigned inventory). As a result, we have determined that disaggregation of our revenues on those bases is not warranted by IFRS 15.114 or relevant guidance.

Our consideration of IFRS 15.B89 included the following:

(a) Type of good or service: As noted above, we disclose revenues in our annual consolidated financial statements disaggregated by the similar nature of the revenues and cash flows attributable to the goods and services within each of our ATS and CCS revenue streams.

Shared attributes within each revenue stream include the degree of government regulation, susceptibility to technology changes and pricing pressures, production complexity, investment requirements, and margin profile, resulting in a generally comparable impact of (and ability to react to) economic factors.

(b) Geographic region: We disclose revenues disaggregated by geographic region representing greater than 10% of consolidated revenue.

(c) Market or type of customer: As noted in clause (a) above, we disaggregate revenue by shared market attributes. Based on the similar characteristics of the product lines within each of our ATS and CCS revenue streams, we do not believe that further disaggregating revenue by sub-markets would depict how our revenues and cash flows are affected by economic factors. Similarly, as noted above, we believe that the end users of our products and services are similarly impacted by economic factors, such that disaggregation of revenues on that basis is not warranted.

(d) Type of contract: Our contracts (which take the form of purchase orders) are similar in type and terms, such that disaggregation on this basis is inapplicable (see response to comment 5 below).

(e) Contract duration: Our contracts typically require delivery within one year. We consider substantially all of our contracts to be short term, such that disaggregating revenues by contract duration would not depict how revenues or cash flows are affected by economic factors.

(f) Timing of transfer or goods or services: We do not believe that the impact of economic factors would differ between our “point in time” and our “over time” contracts. As a result, we have not disaggregated revenues based on the timing of revenue recognition. For example, the impact of global supply shortages similarly constrained both our “over time” and “point in time” revenues.

(g) Sales channels – All of our revenue contracts are obtained through the same sales channel (internal sales personnel). Disaggregating based on this basis would result in all of our revenues being aggregated into one revenue stream such that disaggregation on this basis is inapplicable.

In selecting our ATS and CCS revenue streams as the appropriate categories for disaggregation of revenues, we also considered the guidance set forth in IFRS 15.B88.

IFRS 15.B88 requires entities to consider how the information about the entity’s revenue is presented for other purposes (including in disclosures presented outside of the financial statements, information regularly reviewed by the chief operating decision maker (CODM) for evaluating the financial performance of operating segments, and other information used by an entity or users of an entity’s financial statements to evaluate the entity’s financial performance or make resource allocation decisions). In considering such factors, we note that the disaggregation of our revenues by ATS and CCS revenue streams (as described above) is consistent with the level at which our revenues are disaggregated when they are regularly reviewed by our CODM for evaluating the financial performance of our operating segments. Other categories of revenues are presented outside of the financial statements either in response to form requirements or as otherwise desired to quantify the reasons for material revenue fluctuations between comparative periods.

In summary, we group our revenue contracts into two revenue streams that individually share distinct characteristics, and that reflect how we manage our businesses and operations.

We believe that our current level of revenue disaggregation in our financial statements appropriately depicts how the nature, timing and uncertainty of revenue and cash flows are affected by economic factors. In addition, when selecting the type of categories to use to disaggregate revenue in our financial statements, we considered the guidance in IFRS 15.B88, including the information that is regularly reviewed by our CODM for evaluating the financial performance of our operating segments, information used for internal resource allocation decisions, and disclosures presented outside the financial statements. As a result, we believe that further disaggregation is not required by IFRS

15.114 or the relevant guidance.

Read in the reply
Management's Discussion and Analysis of Financial Condition and Results of Operations · Non-IFRS Financial Measures, page 87
SEC asked (5)
Please revise future filings to provide the disclosures required by IFRS 15.119(b), (d), 120, 122, 126, and 129 or tell us how your current presentation is appropriate. In closing, we remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
CLS answered
Celestica acknowledges the Staff’s comments and respectfully advises the Staff that after the inclusion in future filings of disclosures regarding our use of specified practical expedients as described below, our disclosures with respect to IFRS 15.119(b), (d), 120, 122, 126, and 129 are appropriate.

IFRS 15.119(b) – this item requires a description of significant payment terms (for example, when payment is typically due, whether the contract has a significant financing component, whether the consideration amount is variable and whether the estimate of variable consideration is typically
Rest of the answer

constrained).

Our revenue contracts do not have significant financing components as the contracts are completed within one year and cash is collected on average within 60 to 90 days of invoicing. We rarely enter into revenue contracts with bundled deals with multiple performance obligations

(our contracts typically have only single performance obligations), variable consideration, or that offer significant financing terms

(i.e. payment terms in excess of 1 year). Typically, there are no significant payment terms in our revenue contracts that we believe would be considered useful to the users of our financial statements.

IFRS 15.119(d) – this item requires a description of obligations for returns, refunds and other similar obligations. Our terms with our customers only allow for returns due to workmanship/quality related issues. We do not offer a general return policy for unwanted products. As a result, our return obligations are generally not material, such that disclosure is not required.

IFRS 15.120 – this item requires an entity to disclose specified information about remaining performance obligations. We have not included the disclosures required by this paragraph because we have applied the practical expedient provided by IFRS 15.121. In future filings, we will disclose that we are applying the practical expedient provided by IFRS 15.121.

IFRS 15.122 – this item requires that an entity explain qualitatively whether it is applying the practical expedient in paragraph 121, and whether any consideration from contracts with customers is not included in the transaction price and, therefore, not included in the information disclosed in accordance with paragraph 120. As noted above, in future filings, we will disclose that we are applying the practical expedient provided by IFRS 15.121. In addition, consideration from contracts with customers not included in the transaction price is immaterial.

IFRS 15.126

(a) This item requires information regarding estimates in connection with determining the transaction price. There is no estimation involved in determining the transaction price of our contracts as the consideration is fixed. Further, our typical revenue contracts do not include any variable consideration. Accordingly, this item is inapplicable.

(b) This item requires information on whether an estimate of variable consideration is constrained. As our typical revenue contracts do not include variable consideration, this item is inapplicable.

(c) This item requires information regarding allocation of the transaction price. As noted above, our contracts generally do not include multiple performance obligations that would require the allocation of the transaction price based on standalone selling prices. As a result, this item is inapplicable.

(d) This item requires information regarding returns, refunds and other similar obligations. As noted in our response with respect to

IFRS 15.119(d) above, returns and refunds we experience are not material as our revenue contracts do not provide for a general right of return for unwanted products. Accordingly, this item is inapplicable.

IFRS 15.129 – This item requires disclosure when an entity elects to use the practical expedient in either paragraph 63 or paragraph 94. In future filings, we will include in our disclosures that we apply the practical expedient in paragraph IFRS 15.63. However, we do not apply the practical expedient under IFRS 15.94.

Closing Comments

I sincerely hope that I have addressed the Staff’s comments on the Filing. We are committed to continuous improvement in our filings, and appreciate your comments. I will be pleased to respond promptly to any additional requests for information or material that I may provide in order to facilitate your review.

Read in the reply

Also in this review: request for more time, Jul 22, 2022, closing letter, 2022-08-22

Form 20-F for the Fiscal Year Ended December 31, 2015

2016-09-01 to 2016-09-29 · 1 question · 1 letter from the SEC, 0 from the company
Review closed 2016-09-29
Income taxes
SEC letter of Sep 1, 2016 ↗ no reply letter on EDGAR
Consolidated Financial Statements · Notes to the Consolidated Financial Statements
SEC asked
Income Taxes, page F-42 1. We note your disclosure that during 2015 you recorded a net income tax expense of $42.2 million which was negatively impacted by $12.2 million attributable to taxable foreign exchange impacts. However, we note that the foreign exchange impact described in your rate reconciliation is $3.4 million. Please reconcile these disclosures.
Rest of the question

Further, it appears that there are additional material reconciling items that impacted your tax expense during 2015 including $15.1 million relating to “Other, including non-taxable/non-deductible items and changes to net provisions related to tax uncertainties” and $15.3 million relating to “Change in unrecognized tax losses and deductible temporary differences.” Please further describe the nature of these reconciling items and how they impacted your tax expense. Tell us what consideration you gave to further explaining all of the factors that materially impacted your tax expense for the period.

CLS answered

No reply letter found.

Also in this review: closing letter, 2016-09-29

Schedule TO-I

2015-04-28 to 2015-05-07 · 3 questions · 1 letter from the SEC, 1 from the company
No closing letter
Schedule TO – Item 10. Financial Statements
SEC asked (1)
Please explain in your response letter why you do not believe that the financial information showing the pro forma effect of the tender offer on the Company is material. See Item 1010(b) of Regulation M-A. In this regard, we note that if the Purchase Price is US$11.70 (the minimum Purchase Price in the Offer), you would be purchasing 19.91% of the total issued and outstanding Shares.
CLS answered
Celestica did not initially include information showing the pro-forma effect of the tender offer based on instruction 2 to Item 10 of Schedule TO, which states that financial statements are not considered material when: (a) the consideration offered consists solely of cash; (b) the offer is not subject to any financing condition; and either: (c) the offeror is a public reporting company under Section 13(a) or 15(d) of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended that files reports electronically on EDGAR, or (d) the offer is for all outstanding securities of the
Rest of the answer

subject class, as the Offer meets both clauses (a) and (b), and Celestica meets clause (c). However, after discussions with the Staff, Celestica has amended and supplemented its Schedule TO-I to provide such disclosure, and disseminated such disclosure to shareholders via press release; the press release is also being furnished in a Form 6-K and filed in Canada through SEDAR.

Read in the reply
Offer to Purchase – Withdrawal Rights, page 13
SEC asked (2)
Refer to paragraph 5(d) regarding the extension of the Offer upon certain changes including an increase in price. Revise to clarify that you are referring to business days. See Rule 13e-4(f)(1)(ii).
CLS answered
Celestica’s subordinate voting shares are listed on the Toronto Stock Exchange and the New York Stock Exchange, and the Offer is therefore subject to Canadian and U.S. securities legislation and rules. Paragraph 5(d) reflects a withdrawal right mandated by Canadian legislation under Section 98.1 (1) of the Securities Act (Ontario), which is expressed in terms of calendar days, not business days.
Rest of the answer

Celestica acknowledges that under Rule 13e-4(f)(2)(i), withdrawal rights extend throughout the Offer (reflected in paragraph 5(a)), and that in the event of a price increase, the tender offer will be required to remain open for at least ten business days from the date of notice of such increase, consistent with the provisions of Rule 13e-4(f)(1)(ii). The latter requirement is addressed in paragraph 7 of the Offer to Purchase, “Extension and Variation of the Offer” (found on page 17), where Celestica discloses that subject to applicable law, it may vary the Offer, including an increase in price, and (emphasis added): “If the Corporation varies the terms of the Offer or a change occurs in the information concerning the Offer that would reasonably be expected to affect the decision of the Shareholders to accept or reject the Offer, or if otherwise required by applicable Canadian or U.S. securities laws, the Corporation will extend the time during which the Offer is open to the extent required under such laws.” As a result, Celestica respectively submits that the clarification requested would not be appropriate.

Read in the reply
Extension and Variation of the Offer, page 16
SEC asked (3)
We note the disclosure at the top of page 17 that you have filed an exemptive relief application with securities regulators in Canada “to permit us to extend the Offer in circumstances in which all of the terms and conditions of the Offer have either been satisfied or waived by the Corporation, without first taking up Shares which have been tendered …” Please explain in your response letter, with a view to updated
Rest of the question

and expanded disclosure, the substance of the relief requested and what it would allow you to do. Closing Information Please amend your filing in response to these comments. We may have further comments upon receipt of your amendment; therefore, please allow adequate time after the filing of the amendment for further staff review. You should furnish a response letter with the amendment keying your responses to our comment letter and providing any supplemental information we have requested. You should transmit the letter via EDGAR under the label “CORRESP.” In the event that you believe that compliance with any of the above comments is inappropriate, provide a basis for such belief to the staff in the response letter.

CLS answered
If all of the conditions to the Offer have been complied with or waived by the date the Offer is initially scheduled to expire but the Offer is undersubscribed, Celestica may wish to extend the Offer, which would be permitted by the terms of the Offer and Rule 13e-4. However, under Section 98.3(4) of the Securities Act (Ontario), an issuer may not extend a tender offer (referred to as an “issuer bid”) under these circumstances unless the issuer first takes up all the securities validly tendered and not withdrawn at such initial expiration time (the “Take-up Requirement”).
Rest of the answer

The Take-up Requirement, however, is inconsistent with the provisions of Rule 13e-4, which, among other things, require an issuer to permit withdrawal rights throughout the period during which the offer remains open (including any extension periods), such that an issuer would be prohibited from taking up securities prior to the final expiration of the Offer. As a result, and as noted in paragraph 7 as quoted above (and in paragraph 18 “Legal Matters and Regulatory Approvals” as well), “We have filed an exemptive relief application with securities regulatory authorities in Canada to permit us to extend the Offer, in circumstances in which all of the terms and conditions of the Offer have either been satisfied or waived by us, without first taking up Shares which have been tendered (and not withdrawn) before the Offer was previously scheduled to expire.” Thus the effect of the exemptive relief, if granted, would be to permit Celestica to extend the Offer under these circumstances in compliance with Rule 13e-4. If the exemptive relief application is not granted, Celestica would not be permitted to extend the Offer in the event the Offer is undersubscribed at the original Expiration Time; that possibility is disclosed in the Offer to Purchase immediately following the language quoted in the Staff’s comment above.

Celestica respectfully submits that this disclosure is a clear description of the substance of the relief requested, what it would permit Celestica to do if granted, and the consequences to Celestica if such relief is not granted.

Celestica acknowledges that:

· Celestica is responsible for the adequacy and accuracy of the disclosure in the filing;

· Staff comments or changes to disclosure in response to Staff comments do not foreclose the Commission from taking any action with respect to the filing; and

· Celestica may not assert Staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Read in the reply

Schedule TO-I

2012-11-02 to 2012-11-16 · 10 questions · 2 letters from the SEC, 2 from the company
No closing letter
Legal and contingencies
Item 6. Purposes of the Transaction
SEC asked (1)
Please revise your disclosure to include this disclosure in the offer document as delivered to security holders.
CLS answered
Celestica notes General Instruction E of Schedule TO provides that the statement published, sent or given to security holders may omit negative responses and those that are not applicable. This disclosure is all in the negative (that is, the Corporation has no such plans) and the text is therefore omitted from the Circular.
Read in the reply
Offer to Purchase · Forward-Looking Information, page iv
SEC asked (2)
We note your reference to forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 in this section and your claim of the protection offered by that Act. Note that the safe harbor protections for forward-looking statements contained in the federal securities laws do not apply to statements made in connection with a tender offer.
Rest of the question

See Section 21E(b)(2)(C) of the Securities Exchange Act of 1934 and Regulation M-A telephone interpretation M.2 available at www.sec.gov in the July 2001 Supplement to the Division of Corporation Finance’s Manual of Publicly Available Telephone Interpretations. Please revise to delete the reference and confirm that you will avoid making reference to that Act in all future communications in connection with the tender offer.

CLS answered
Celestica notes the Staff’s comment and confirms that it will not make any reference to the Private Securities Litigation Reform Act of 1995 in any future communications in connection with the tender offer and will not seek the protection offered by that Act for purposes of statements made in connection with the Offer. Amendment No. 1 to Celestica’s Schedule TO-I deletes such reference.
Read in the reply
Summary, page 1
SEC asked (3)
Please revise the penultimate question on page 4 to comply with rule 14e-1(c) which requires payment to be prompt, not “as promptly as practicable.”
CLS answered
The Corporation acknowledges its obligation to make prompt payment for the Shares following expiration of the Offer. Amendment No. 1 to the Corporation’s Schedule TO-I includes a revised question and answer, replacing the reference to “as promptly as practicable” with “promptly.”
Read in the reply
Conditions of the Offer, page 12
SEC asked (4)
We note the language in the first paragraph of this section that you may effectively assert a condition “at any time before the payment for any such Shares.” We also note the language in the penultimate paragraph of this section that you have reserved the right to assert the occurrence of any of the conditions to the offer “at any time and from time to time.” This type of disclosure suggests that conditions to the
Rest of the question

offer may be raised or asserted after expiration of the offer. Please be advised that all conditions to the offer, other than those subject to applicable law, must be satisfied or waived before the expiration of the offer. Revise the referenced disclosure to make clear that all conditions, other than those subject to government approvals, will be satisfied or waived on or before expiration of the offer.

CLS answered
The Corporation acknowledges that all conditions to the Offer (other than those subject to government approvals) must be satisfied or waived at or prior to the expiration of the Offer. Amendment No.1 to Celestica’s Schedule TO-I includes an explicit statement to this effect and revises the referenced disclosure.
Read in the reply
Conditions of the Offer, page 12
SEC asked (5)
We note your condition (f). You may condition a tender offer on any number of conditions, as long as they are described with reasonable specificity, capable of objective verification, and outside of your control. Please tell us what consideration you have given to revising the condition such that it is not so overly broad as to render your offer illusory.
CLS answered
Celestica has noted the Staff’s comment, and does not believe that the condition set forth in clause (f) is so overly broad as to render the Offer illusory. Significantly, Celestica must (1) act “reasonably” and (2) determine the “fair market value” of a Share — a standard commonly referred to in business transactions and generally viewed as that price a willing buyer will pay a willing seller, each acting at arm’s length and under no compulsion to act. This may not be the equivalent of the trading price of the Shares on either the TSX or the NYSE.
Rest of the answer

To conclude that this condition has been triggered, Celestica would need to consider appropriate objective indicia of fair market value at the relevant time. This determination could, but would not necessarily, include reliance on an opinion of a third party financial advisor.

Read in the reply
Conditions of the Offer, page 12
SEC asked (6)
We note your condition (j) relating to a Rule 13e-3 transaction. We also note the subsequent paragraph in which you state that you may waive conditions. Please tell us whether you may waive the above-referenced condition and the effect such a waiver would have on your offer given the likelihood that your offer may be subject to Rule 13e3 as a result of the waiver.
CLS answered
The Corporation acknowledges that it is not permitted to waive the condition set forth in clause (j) unless it first takes the steps required so that the Offer would be in compliance with Rule 13e-3. The Corporation respectfully notes that in light of the maximum size of the Offer ($175 million) and the market capitalization of the outstanding Shares (more than $1.3 billion at November 1, 2012), circumstances that would cause this condition to be triggered are unlikely to occur.
Read in the reply
Conditions of the Offer, page 12
SEC asked (7)
We note the language in the last paragraph in this section that the your failure “at any time to exercise its rights under any of the foregoing conditions shall not be deemed a waiver of any such right.” If an event triggers a listed offer condition, and you determine to proceed with the offer anyway, you have waived the offer condition.
Rest of the question

When an offer condition is triggered by events that occur during the offer period and before the expiration of the offer, you should inform security holders how you intend to proceed promptly, rather than waiting until the end of the offer period, unless the condition is one where satisfaction of the condition may be determined only upon expiration. Please confirm your understanding supplementally.

CLS answered
Celestica supplementally confirms to the Staff Celestica’s understanding that: (1) if an event triggers a listed Offer condition and Celestica decides to take up and pay for Shares properly tendered and not withdrawn, this constitutes a waiver by Celestica of the triggered condition(s); and (2) if an Offer condition is triggered by events that occur during the Offer period and before the expiration of the Offer, when the Corporation has determined how it intends to proceed it will promptly inform security holders of its intention rather than waiting until the end of the Offer period, unless
Rest of the answer

the condition is one where satisfaction of the condition may only be determined upon expiration.

Read in the reply
Conditions of the Offer, page 12
SEC asked (8)
With respect to the same paragraph referenced immediately above, we note that the disclosure suggests that once an offer condition is triggered, you must decide whether or not to waive the condition. When a condition is triggered and you decide to proceed with the offer anyway, we believe that this constitutes a waiver of the triggered condition(s).
Rest of the question

Depending on the materiality of the waived condition and the number of days remaining in the offer, you may be required to extend the offer and recirculate new disclosure to security holders. You may not, as this language seems to imply, simply fail to assert a triggered offer condition and thus effectively waive it without officially doing so. Please

CLS answered
Celestica supplementally confirms to the Staff Celestica’s understanding that if an event triggers a listed Offer condition and Celestica decides to take up and pay for Shares properly tendered to the Offer and not withdrawn, this constitutes a waiver by the Corporation of the triggered condition(s). The Corporation acknowledges that, depending on the materiality of the waived condition and the number of days remaining in the Offer, the Corporation may be required to extend the Offer and circulate new disclosure to security holders.
Read in the reply
Ownership of Securities of the Company, page 32
SEC asked (9)
Please disclose the names of the individuals who have beneficial ownership of the shares held of record by Onex Corporation and MacKenzie Financial Corporation.
CLS answered
As stated in footnote 4 of the ownership table, the Shares and multiple voting shares owned by Onex Corporation are included as being owned beneficially by Mr. Gerald Schwartz.

Celestica has no knowledge of any individual who has beneficial ownership of the Shares held of record by Mackenzie Financial Corporation (“Mackenzie”). Mackenzie’s Schedule 13G filed with the Commission on February 14, 2012 states that it holds sole investment and dispositive power over the Shares referred to in that Schedule.
Rest of the answer

Mackenzie includes the following statement in its alternative monthly report for February 2012 filed on SEDAR: “Mackenzie specifically disclaims any beneficial ownership of the reported common shares, but as investment manager it maintains exclusive power to exercise investment control or direction over such common shares for its managed accounts as the beneficial owners.”

* * *

Celestica does not believe, and we concur with Celestica, that the information it has provided in Amendment No. 1 to its Schedule TO-I does not constitute a material change in the information it has provided previously in the Circular within the meaning of Rule 13e-4(d)(2).

Celestica acknowledges that:

· Celestica is responsible for the adequacy and accuracy of the disclosure in the filing;

· Staff comments or changes to disclosure in response to Staff comments do not foreclose the Commission from taking any action with respect to the filing; and

· Celestica may not assert Staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Read in the reply
Offer to Purchase · Conditions of the Offer, page 12
SEC asked
We note your response to prior comment 5 and we reissue it. As currently drafted, condition (f) is not described with reasonable specificity and capable of objective verification: security holders have no parameters to determine your meaning of “fair market value.” In addition, the determination of Purchase Price will necessarily have to be made after the offer expires and, as we stated in our prior comment 4, all
Rest of the question

conditions to the offer, other than those subject to applicable law, must be satisfied or waived before the expiration of the offer. Please revise.

CLS answered
In response to the Staff’s comment, Amendment No. 2 to Celestica’s Schedule TO-I includes the following:

Items 1 through 11.

1. The section “Conditions of the Offer” of the Offer to Purchase is hereby amended and supplemented as follows:

The following sentence is inserted as the third sentence of the last paragraph of this section:

On November 16, 2012, the Corporation publicly announced that it has waived the condition contained in (f) above.
Read in the reply

Form 20-F

2012-06-21 to 2012-08-27 · 6 questions · 1 letter from the SEC, 1 from the company
Review closed 2012-08-27
Legal and contingencies
Selected Financial Data, page 3
SEC asked (1)
Refer to the presentation of selected financial data on page 4. We note that you have presented four years of financial data, and other financial data based on Canadian GAAP and net earnings and loss data based on US GAAP for each of the four years ended December 31, 2010. Please state the basis for this presentation, including the reference to U.S.
Rest of the question

GAAP and how you determined how your presentation of these Canadian and U.S. GAAP amounts is appropriate. Refer to Form 20-F General Instructions, Instruction 1.

CLS answered
Item 3.A of Form 20-F requires selected historical financial data for the five most recent financial years and General Instruction G to Form 20-F requires selected historical financial data prepared in accordance with IFRS for the two most recent financial years. Instruction 1 to General Instruction G to Form 20-F permits an eligible issuer to elect to include, refer to, or incorporate by reference financial data prepared in accordance with Previous GAAP (i.e., Canadian GAAP for Celestica).
Rest of the answer

Therefore, we provided selected financial data for fiscal years ended December 31, 2011 and 2010 based on IFRS and for fiscal years ended December 31, 2009, 2008 and 2007 based on Canadian GAAP. With respect to the selected financial data for fiscal year ended December 31, 2010, since it was originally prepared in accordance with Canadian GAAP, as mentioned in the notes to the selected financial data in Item 3.A, we included such financial data for fiscal year ended December 31, 2010 based on Canadian GAAP solely to provide a meaningful comparison to the 2009 and prior years’ information. With respect to the financial information based on U.S. GAAP, Instruction 2 to Item 3.A requires reconciliations of the data to U.S. GAAP if a basis of accounting other than IFRS is used. Since financial data based on Canadian GAAP was included for four years ended December 31, 2010, we determined that it was appropriate to include financial information based on U.S. GAAP for these four years.

The selected financial data for the four years ended December 31, 2010 based on Canadian GAAP and the information based on U.S. GAAP is the same as the information we previously disclosed in Item 3.A of the Annual Report on Form 20-F for the fiscal year ended December 31, 2010, filed with the Commission on March 24, 2011.

Read in the reply
Summary of 2011, page 35
SEC asked (2)
Your tabular presentation includes Canadian GAAP key operating results for the years ended December 31, 2009 and 2010 within the same table, and side-by-side, with IFRS key operating results for the years ended December 31, 2010 and 2011. Please tell us how this presentation complies with General Instruction G.3. to Form 20-F. Other performance indicators, page 37
CLS answered
We acknowledge that General Instruction G.3. requires that previous GAAP financial information should not be presented side-by-side with IFRS financial information. We believe that the current presentation is clear to investors. However, we will comply with this format requirement in future filings.
Read in the reply
Summary of 2011, page 35
SEC asked (3)
We note that in the introduction to the quarterly presentation of cash cycle days that you refer to the quarterly cash cycle data as being “non-IFRS measures.” Following the table, you then state that the transition from GAAP to IFRS did not impact the calculation of your performance indicators. Please clarify that the balances used in computing these amounts are based on IFRS amounts for each quarter.
Rest of the question

In this regard, explain why these indicators are being labeled as non-IFRS measures.

CLS answered
We calculate cash cycle days using inputs such as accounts receivable, inventory and revenue, which are based on IFRS amounts for each quarter as reported on our balance sheet and statement of operations for those respective periods. We have labeled cash cycle days as a non-IFRS measure as there is no prescribed meaning of cash cycle days under IFRS.
Read in the reply
Notes to the Consolidated Financial Statements · Note 11. Provisions, page F-28
SEC asked (4)
We note that you have provided the information required by paragraph 84 of IAS 37. Please tell us what consideration you have given to providing the disclosures required by paragraphs 85 and 86 of that standard.
CLS answered
The disclosures required by paragraphs 85 (a) and (b) of IAS 37 for our restructuring provision are included in notes 16 (a) and note 2 (m) to our 2011 consolidated financial statements. In future filings, we will add an appropriate cross reference. There were no material uncertainties or expected reimbursements to be disclosed under paragraph 85 (b) and (c) of IAS 37.

The disclosures required by paragraphs 85 (a) and (b) of IAS 37 for our warranty provision are included in note 2 (m) to our 2011 consolidated financial statements.
Rest of the answer

In future filings, we will add an appropriate cross reference. There were no material uncertainties or expected reimbursements to be disclosed under paragraphs 85 (b) and (c) of IAS 37.

Our other provisions are comprised of our legal provision, certain other provisions and liabilities, and asset retirement obligations. Other provisions as at December 31, 2011 included $3.2 million of contingent consideration related to an acquisition disclosed in note 4 to the 2011 consolidated financial statements. In future filings, we will add an appropriate cross reference to comply with paragraphs 85 (a) and (b) of IAS 37. The disclosures required by paragraphs 85 (a) and (b) of IAS 37 for legal provisions are included in note 2 (m) to the 2011 consolidated financial statements. Included in the other provisions was $3.9 million for asset retirement obligations at December 31, 2011. We will consider adding the disclosures required by paragraph 85 if our asset retirement obligation balance increases significantly in future years. There were no material uncertainties or expected reimbursements for any of our other provisions to be disclosed under paragraphs 85 (b) and (c) of IAS 37.

To the extent the uncertainties or expected reimbursements are material in future periods, we will include the required disclosures in the footnotes to the consolidated financial statements.

The disclosures required by paragraph 86 of IAS 37, which refers to contingent liabilities are included in note 24 to the 2011 consolidated financial statements.

Read in the reply
Notes to the Consolidated Financial Statements · Note 11. Provisions, page F-28
SEC asked (5)
We note that the provision included in the “Other” column “includes legal provisions, certain other provisions and liabilities and asset retirement obligations.” Please tell us how you determined that these provisions were sufficiently similar such that aggregation is appropriate.
Rest of the question

In this regard, the nature of the provisions described on pages F-13 and F14 suggest that these items fulfill the requirements of paragraphs 85(a) and (b) and 86(a) and (b) of IAS 37. Refer also to paragraph 87. Note 24. Commitments, Contingencies and Guarantees:

CLS answered
We have aggregated our legal provision, certain other provisions and liabilities, and asset retirement obligations as a single class for disclosure purposes based on the materiality of the individual amounts. We specifically segregated our warranty and restructuring provisions due to the materiality of those provisions. As at December 31, 2011, other provisions included $3.2 million related to an acquisition (see question 4 above), $3.9 million of asset retirement obligations and the remainder of the balance was comprised of legal and other, none of which individually exceeded $1.5 million.
Rest of the answer

Based on these amounts, we determined it was appropriate to aggregate these smaller balances for disclosure.

To the extent that these or other provisions are individually material in future periods, we will include separate disclosure in the provisions footnote to the consolidated financial statements.

Note 24. Commitments, Contingencies and Guarantees:

Read in the reply
Litigation, page F-48
SEC asked (6)
We note that the motion to dismiss the 2007 suits described in the second paragraph of this section was granted in October 14, 2010 by the District Court and then reversed on December 29, 2011 by the Court of Appeals and remanded for further proceedings. The differences in the findings of the two courts suggest that the possibility of an outflow in settlement might be more than remote.
Rest of the question

Please tell us what consideration you have given to providing the disclosure set forth in paragraphs 86 of IAS 37.

CLS answered
Notwithstanding the reversal by the Court of Appeals, we continue to believe the possibility of any outflow in settlement is remote. We continue to believe that the claim is without merit and intend to vigorously defend same. In any event, we believe we have sufficient liability insurance coverage to pay any such settlement.

* * *

We do not believe that the information we have provided in this response to the Staff’s comments materially changes the information we have provided previously in the Filing.

We also acknowledge that we are responsible for the adequacy and accuracy of the
Rest of the answer

disclosure in the Filing, Staff comments or changes to disclosure in response to Staff comments do not foreclose the Commission from taking any action with respect to the Filings, and we may not assert Staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Read in the reply

Also in this review: closing letter, 2012-08-27

Form 20-F for the Fiscal Year Ended December 31, 2009

2010-06-04 to 2010-08-17 · 15 questions · 2 letters from the SEC, 3 from the company
Review closed 2010-08-17
InventoryNon-GAAP measuresRevenueRisk factorsResults discussion (MD&A)Liquidity and cash
SEC asked (1)
We note that Research in Motion accounted for 17% of your total revenues in the fiscal year 2009. With a view towards future filings, tell us what consideration you have given to including a summary description of the material terms of your agreement with Research in Motion in your Business Overview section. Refer to Item 4.B.6 of Form 20-F.
Rest of the question

Also, please tell us whether you have a contract with this entity, and, if so, provide us with your analysis as to whether you are required to file this contract as an exhibit to your Form 20-F. Refer to Instruction 4 of the Instructions as to Exhibits in Form 20-F. “Competitors with component manufacturing capabilities may have greater opportunities than we do to win additional business from some of our customers. . . .,” page 8

CLS answered
We generally enter into master supply agreements with our customers that provide the framework for our overall relationship. These agreements do not typically guarantee a particular level of business or fixed pricing. Instead, we bid on a project-by-project basis and receive customer purchase orders for specific quantity and timing of products.
Rest of the answer

Because the master supply agreements are ordinary course and provide general terms for the sale of goods or services, we do not believe that any of these agreements are required to be filed as exhibits to our Form 20-F.

We have agreements in place with Research in Motion (RIM) that cover general terms of manufacturing and repair. We bid on RIM’s business on a project-by-project basis, and RIM purchases from Celestica are by individual purchase orders. Because of the structure of our business relationship with RIM, we do not believe that there is any agreement that is required to be filed as an exhibit to our Form 20-F

“Competitors with component manufacturing capabilities may have greater opportunities than we do to win additional business from some of our customers....,” page 8

Read in the reply
SEC asked (2)
You state that you procure all of your components from third-party suppliers. However, you do not appear to have filed as exhibits to your Form 20-F any contracts with these suppliers or included a summary description of any arrangements with such suppliers that may be material to your business.
Rest of the question

With a view towards future filings, consider including a description of the material terms of any material agreements you may have with these suppliers in your Business Overview section. Tell us whether you have contracts with any of these entities, and, if so, provide us with your analysis as to whether you are required to file these contracts as exhibits to your Form 20-F. Refer to Instruction 4 of the Instructions as to Exhibits in Form 20- F. “The interest of our controlling shareholder may conflict with the interest of the remaining holders of our subordinate voting shares,” page 15

CLS answered
We generally do not enter into master purchase agreements with our suppliers and we have no individual supplier that accounts for more than 10% of our purchases. We procure substantially all of our materials and components pursuant to individual purchase orders that are short-term in nature.

We do not believe there are any material supply agreements to be described in the Business Overview or to be filed as exhibits to our Form 20-F.

“The interest of our controlling shareholder may conflict with the interest of the remaining holders of our subordinate voting shares,” page 15
Read in the reply
SEC asked (3)
We note that Onex Corporation holds approximately 69% of the voting interest in your company. In your future filings, consider revising your risk factor caption to convey clearly that Onex Corporation holds 69% of the voting interest in your company. Also, expand your disclosure to describe in more detail the controlling interest relationship held by Onex Corporation in your Business Overview section.
Rest of the question

Further, it appears that you are not relying upon the exception for controlled companies to Section 303A of the NYSE Listed Company Manual, Corporate Governance Standards, but the exception for foreign private issuers to this section. Please confirm. “The efficiency of our operations could be adversely affected by any disruptions from our third-party IT providers,” page 14

CLS answered
In response to the Staff’s comment, in future filings, we will revise the wording of this Risk

Factor caption to state specifically the percentage of Onex’s voting interest in Celestica, and we will add to our Business Overview section a description of

Onex’s controlling interest.

We confirm that Celestica relies on the foreign private issuer exception from Section 303A of the

NYSE Listed Company Manual in connection with its compliance with the NYSE

Listed Company Manual rather than the controlled company exception contained in

Section 303A.
Read in the reply
SEC asked (4)
We note that you have outsourced IT systems support for your production control and inventory management systems and that your operations could be adversely affected by any disruptions from these third-party providers.
Rest of the question

Tell us what consideration you have given to including disclosure of the material terms of these agreements in your disclosure and whether these agreements should be filed as exhibits to your Form 20- F. Refer to Instruction 4(b)(ii) of the Instructions as to Exhibits in Form 20-F.

CLS answered
Our outsourcing agreement with a third-party provider of IT services can be terminated in whole or in part, upon six months’ notice, at any time after November 2010. The services provided under this agreement are not unique and similar services could be performed in-house or by multiple other global third-party infrastructure outsourcing providers.
Rest of the answer

We are not substantially dependent on this agreement, and have therefore not filed it as an exhibit to our Form 20-F.

In future filings, if we retain this risk factor we will revise it to note that the overall risk is the loss of IT services (not a risk with respect to this single provider) that could have a significant short-term impact on our operations.

Item 5. Operating and

Financial Review and Prospects

Management’s Discussion and

Analysis of Financial Condition and Results of Operations

Operating Results,

Read in the reply
Management’s Discussion and Analysis of Financial Condition and Results of Operations · Operating Results, page 34
SEC asked (5)
Your discussion of the results of operations frequently does not quantify sources of material changes. For example, refer to disclosure on page 37 addressing the decrease in gross profits and decrease in selling, general and administrative expenses.
Rest of the question

Please note that prefacing a reference to the source or sources of changes with the word “primarily” obscures the ability of the reader to identify the material sources of the change. In addition, where a material change is attributed to two or more factors, including any offsetting factors, the contribution of each identified factor should be described in quantified terms. See Section III.D of SEC Release No. 34-26831. To the extent possible, please quantify the sources of material changes and offsetting factors.

CLS answered
We note the

Staff’s comment and we will quantify the sources of material changes and offsetting factors in future filings.
Read in the reply
Revenue, page 35
SEC asked (6)
Please clarify your statement that revenue decreased in all end markets, other than the consumer market, which was relatively flat compared with 2008, as we note from your table on page 35 that consumer revenue increased from 23% in the fiscal year 2008 to 29% in 2009.
CLS answered
Our statement that “revenue decreased in all end markets, other than the consumer market, which was relatively flat” refers to a change in absolute revenue dollars versus a change in percentage of total revenue. Revenue for the consumer market was approximately $1.8 billion for each of 2009 and 2008. In future filings, we will clarify our statement to identify that we are referring to revenue dollars.
Read in the reply
Unaudited Quarterly Financial Highlights, page 50
SEC asked (7)
Refer to the tabular reconciliations of Canadian GAAP earnings (loss) to adjusted net earnings and other non-GAAP metrics on page 52. We believe that the non-GAAP operating statement columnar format appearing on page 52 conveys undue prominence to statements based on non-GAAP information and, generally, should not be presented.
Rest of the question

As a substitute for this presentation format, you may consider presenting only individual non-GAAP measures (i.e., line items, subtotals, etc.) provided each one complies with Item 10(e).

CLS answered
In light of the

Staff’s comment, we will amend our presentation of non-GAAP measures in future filings. A sample presentation for illustrative purposes only is set forth below:

Reconciliation of GAAP to Non-GAAP measures:

Three months ended

Six months ended

June

2009

2010

% of revenue

GAAP gross profit

Stock-based compensation

Non-GAAP gross profit

GAAP SG&A

Non-GAAP SG&A

GAAP earnings before tax

Interest expense or income

Amortization of intangible assets (excluding amortization of computer software)

Goodwill and long-lived asset write-down

Gains or losses on the repurchase
Rest of the answer

of shares or debt

Restructuring and other costs

Non-GAAP operating earnings (EBIAT)

GAAP net earnings

Tax effect of above and deferred tax write-offs or recoveries

Non-GAAP adjusted net earnings

Diluted EPS

GAAP

- earnings per share

Non-GAAP

- adjusted net earnings per share

Read in the reply
Unaudited Quarterly Financial Highlights, page 50
SEC asked (8)
We note that “management uses these non-GAAP measures to assess operating performance.” Please more fully describe the specific ways in which management uses each of these measures to conduct or evaluate the business.
Rest of the question

Your discussion should also describe the economic substance behind management’s decision to use each measure, the material limitations associated with the use of the non-GAAP financial measures and the manner in which management compensates for these limitations when using the non-GAAP measures.

CLS answered
We propose to include in future SEC filings and in press releases that refer to non-GAAP measures language similar to that set forth below, and will provide a more comprehensive description of management’s rationale for using each of these measures in the conduct or evaluation of our business:

Use of Non-GAAP

Measures

To supplement our unaudited selected financial data presented on a basis consistent with GAAP, the table set forth herein [this table would be comparable to the table included in our response to question 7] includes non-GAAP measures for gross profit, gross margin, selling,
Rest of the answer

general and administrative expenses (SG&A), operating earnings, operating margin, adjusted net earnings, adjusted net earnings per share, return on invested capital and free cash flow.

In calculating these non-GAAP financial measures, management excludes the following items: stock-based compensation, amortization of intangible assets (excluding amortization of computer software), restructuring and other charges (most significantly restructuring charges), the write-down of goodwill and long-lived assets, and gains or losses related to the repurchase of shares and debt, net of tax and significant deferred tax write-offs or recoveries.

Management uses non-GAAP measures (1) to assess operating performance and the effective use and allocation of resources, (2) to provide more meaningful period-to-period comparisons of operating results, both internally and against operating results of competitors, (3) to enhance investors’ understanding of the core operating results of the business and (4) to set management incentive targets.

We believe investors use both GAAP and non-GAAP measures to assess management’s current, future and past decisions associated with strategy and allocation of capital, as well as to analyze how businesses operate in, or respond to, swings in economic cycle or to other events that impact core operations.

These non-GAAP measures do not have any standardized meaning prescribed by Canadian or U.S. GAAP. Non-GAAP measures are not measures of performance under Canadian or U.S. GAAP and should not be considered in isolation or as a substitute for any standardized measure under Canadian or U.S. GAAP. The most significant limitation to management’s use of non-GAAP financial measures is that the charges and expenses excluded from the non-GAAP measures are nonetheless charges required to be recognized under GAAP and have an economic impact on the Company. Management compensates for these limitations primarily by issuing GAAP results to show a complete picture of the Company’s performance, and reconciling non-GAAP results back to

GAAP.

The economic substance of these exclusions and management’s rationale for excluding these from non-GAAP financial measures is provided below:

Compensation, which represents the estimated fair value of stock options and restricted stock units granted to employees, is excluded since grant activities vary significantly from quarter to quarter in both quantity and fair value. In addition, excluding this expense allows us to better compare core operating results with those of our competitors who also generally exclude stock-based compensation from their core operating results, and who may have different granting patterns and types of equity awards and who may use different option valuation assumptions than we do.

charges (excluding amortization of computer software) consists of non-cash charges against intangible assets that are impacted by the timing and magnitude of acquired businesses. Amortization of intangibles varies among competitors, and we believe that excluding these charges permits a better comparison of core operating results with those of our competitors who also exclude amortization charges.

and Other Costs, which consist of severance, lease termination and facility exit costs associated with closing and consolidating manufacturing facilities, reductions in infrastructure and costs associated with the integration of acquired businesses into our operations, are excluded because such charges are not directly related to ongoing operating results and do not reflect expected future operating expenses after completion of these activities.

We believe that excluding these charges permit a better comparison of our core operating results with those of our competitors who also generally exclude these costs in assessing operating performance.

Impairment

Charges, which consist of non-cash charges against goodwill and long-lived assets, resulting primarily when the carrying value of these assets exceeds their fair value. These charges are excluded because they are generally non-recurring. In addition, our competitors may record impairment charges at different times and excluding these charges permits a better comparison of our core operating results with those of our competitors who also generally exclude these charges in assessing operating performance.

Gains or losses related to the repurchase of shares and debt are excluded as these gains or losses do not impact core operating performance and vary significantly among our competitors who also generally exclude these charges in assessing operating performance.

Significant deferred tax write-offs or recoveries are excluded as these write-offs or recoveries do not impact core operating performance and vary

Free cash flow is a measure used by management in addition to cash flow from operations. We believe free cash flow provides another level of transparency of our liquidity as it represents cash generated after the purchase of capital equipment or property.

Read in the reply
Unaudited Quarterly Financial Highlights, page 50
SEC asked (9)
We note that management uses free cash flow as a measure to assess cash flow performance and that there is no comparable measure under GAAP. Tell us how you determined that free cash flow does not represent a liquidity measure, the most comparable measure under GAAP being operating cash flows.
CLS answered
We have reviewed the disclosure on page 52, note (6) regarding free cash flow and do not believe we represented that free cash flow is not a liquidity measure. We do highlight that free cash flow does not have a standard meaning as prescribed by Canadian or U.S. GAAP. In future filings, we will provide a reconciliation of free cash flow to operating cash flow, deducting capital expenditures (net of proceeds from the sale of surplus property and equipment).
Read in the reply
Unaudited Quarterly Financial Highlights, page 50
SEC asked (10)
We note that the guidance for the first quarter of 2010 presented on page 54 includes “Adjusted net earnings per share, using the revised definition.” Please tell us how you determined that your presentation of this range complies with Item 10(e) of Regulation S-K.
Rest of the question

In this regard, you do not appear to have provided a reconciliation between the non-GAAP range presented and the most directly comparable GAAP measure range.

CLS answered
Our guidance includes a range for adjusted net earnings per share which we believe is an important metric for investors to understand our core operating performance and to compare our operating results against our competitors. Historically, we have not reconciled the range of adjusted net earnings per share to GAAP net earnings per share due to the inherent uncertainties associated with forecasting the amount and timing of restructuring, impairment and other items.

We will, in future filings, provide a range of the estimated per share impact for items we can reasonably forecast, which will
Rest of the answer

include stock-based compensation, restructuring and amortization charges.

Read in the reply
Unaudited Quarterly Financial Highlights, page 50
SEC asked (11)
We have similar concerns regarding the non-GAAP presentations made within the press releases and exhibits filed with Forms 6-K on January 27, 2010 and April 27, 2010 that are incorporated by reference into your registration statements. Consolidated Financial Statements Notes to the Consolidated Financial Statements Note 2. Significant Accounting Policies (f) Inventories, page F-10
CLS answered
See our responses to questions 9 and 10. We will endeavor to provide similar information for future press releases that include non-GAAP presentations.

Consolidated Financial

Statements

Notes to the Consolidated

Financial Statements

Note 2. Significant

Accounting Policies

(f) Inventories, page F-10
Read in the reply
Unaudited Quarterly Financial Highlights, page 50
SEC asked (12)
We note that in 2009 you recorded a net inventory valuation reversal of $1.0. Identify the components, and their amounts, that result in this adjustment amount. For any component that has the effect of increasing the value of your inventory, explain how your accounting complies with paragraph ASC 330-10-35.
Rest of the question

In this regard, we note that your reconciliation between Canadian and US GAAP policies does not identify a difference in how inventory is accounted for. * * * * * * * Please respond to these comments within 10 business days or tell us when you will provide us with a response. Please submit all correspondence and supplemental materials on EDGAR as required by Rule 101 of Regulation S-T. If you amend your filing(s), you may wish to provide us with marked copies of any amendment to expedite our review. Please furnish a cover letter that keys your response to our comments and provides any requested information. Detailed cover letters greatly facilitate our review. Please understand that we may have additional comments after reviewing any amendment and your response to our

CLS answered
The $1 million inventory valuation reversal represents a realized gain on sale of inventory to third parties that was previously written down. Consistent with ASC 330-10-35, none of this amount has the effect of increasing the value of inventory on hand at December

31, 2009.

*

* *

We do not believe that the information we have provided in this response to the Staff’s comments materially changes the information we have provided previously in the Filing.
Read in the reply
SEC asked (1)
In response to prior comment 1, you state that the master supply agreements are made during the ordinary course of business and that because of the structure of your business relationship with Research in Motion, you do not believe that there is any agreement required to be filed to your Form 20-F.
Rest of the question

Given that Research in Motion accounted for 17% of your total revenues in fiscal year 2009, in your response letter and with a view towards expanded disclosure in future filings, please provide us with additional analysis as to whether you are substantially dependent on your agreements with Research in Motion. Refer to Item 4.B.6 and Instruction 4 of the Instructions as to Exhibits in Form 20-F. Item 8. Financial Information Notes to the Consolidated Financial Statements Note 2. Significant Accounting Policies (f) Inventories, page F-10

CLS answered

No numbered answer found in the reply. Read the reply ↗

SEC asked (2)
We note your response to prior comment 12. As we previously noted, your reconciliation between Canadian and US GAAP does not identify a difference in how inventory is accounted for. US GAAP, as set forth in ASC 330-10-35-14 and ASC 330-10-S99-9, indicates that an inventory write-down establishes a new cost basis.
Rest of the question

In this regard, please explain whether you account for inventory allowances differently under either GAAP. If the policy is the same, tell us why you believe that your accounting is proper. Other

CLS answered

No numbered answer found in the reply. Read the reply ↗

SEC asked (3)
As previously requested, in connection with responding to our comments, please provide, in writing, a statement from the company acknowledging that: • the company is responsible for the adequacy and accuracy of the disclosure in the filing; • staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and • the company may
Rest of the question

not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

CLS answered
Item 4.B.6 in Form 20-F requires summary information regarding the extent to which the registrant is dependent on various types of contracts, including commercial contracts with customers. In response to this item, we describe the importance to us of our customers with revenues in excess of 10% of our gross revenue and our top 10 customers.
Rest of the answer

As stated in our previous response, we will also expand our disclosure to note that, with most of these customers, our only “contracts” are framework agreement that do not include volume or price guarantees.

Instruction 4 of the Instructions as to

Exhibits in Form 20F refers to contracts on which the registrant is substantially dependent. As previously described to the Staff, our only agreements with Research in Motion (RIM) outline the framework for manufacturing protocol and repairs and do not specify minimum quantities, price, etc. We are not dependent on these agreements; rather, our relationship is dependent upon individual purchase orders issued by RIM (of which there were more than

1,869 in first quarter 2010). We have not filed an agreement with RIM as an exhibit to the Form 20-F because there is no agreement with RIM on which we are substantially dependent.

8. Financial Information

Notes to the Consolidated Financial Statements

Note

2. Significant Accounting Policies

(f) Inventories, page F-10

2. We note your response to prior comment 12. As we previously noted, your reconciliation between Canadian and US GAAP does not identify a difference in how inventory is accounted for. US GAAP, as set forth in ASC 330-10-35-14 and ASC 330-10-S99-9, indicates that an inventory write-down establishes a new cost basis. In this regard, please explain whether you account for inventory allowances differently under either GAAP. If the policy is the same, tell us why you believe that your accounting is proper.

RESPONSE: For US GAAP, we adhere to

ASC 330-10-35-14 and ASC 330-10-S99-9 which state that the write down of inventory to lower of cost and market creates a new cost basis for the inventory. Both ASC 330-10-35-14 and ASC

330-10-S99-9 prohibit the write-up of inventory due to reversal of previous inventory impairments. We acknowledge that this differs from Canadian GAAP; however, as noted in our June 28, 2010 response, we did not identify any amounts that had the effect of increasing the cost of inventory at December 31, 2009. The

$1 million inventory valuation reversal represented a realized gain on sale of inventory to third parties that was previously written down. If we identify future inventory reversals under Canadian GAAP, we will adjust these as part of our reconciliation between

Canadian and US GAAP.

* * *

We do not believe that the information we have provided in this response to the Staff’s comments materially changes the information we have provided previously in the Filing.

Read in the reply

Also in this review: company letter, Jun 11, 2010, closing letter, 2010-08-17

Form 20-F for the fiscal year ended December 31, 2006

2007-11-30 to 2008-01-16 · 7 questions · 2 letters from the SEC, 2 from the company
Review closed 2008-01-16
Results discussion (MD&A)RevenueControlsRisk factorsLegal and contingencies
Item 4. Information on the Company · Celestica’s Focus, page 19
SEC asked (1)
We note your disclosure here and throughout th e annual report of operational problems that you experienced at your facility in Mexico during 2006. Further description of the problems experienced at the facility, qualitative and quantitative disclosure of the impact such problems have had on your financial condition and results of operations, and discussion of the relationship between the problems at the facility
Rest of the question

and the class action lawsuit you disclose on page 42 appears warranted. Please advise.

CLS answered

No numbered answer found in the reply. Read the reply ↗

Customers, page 23
SEC asked (2)
We note your disclosure that Cisco Systems and IBM each accounted for 10% of your total revenues in 2006. A description of your contractual arrangements with these customers appears warranted. Also, you do not appear to have filed agreements with either customer as exhibits to your annual report.
Rest of the question

Please advise whether you are substantially dependent upon these customers for purposes of Instruction 4(b)(ii) of the Instructions as to Exhibits in Form 20-F.

CLS answered

No numbered answer found in the reply. Read the reply ↗

Item 5. Operating and Financial Review and Prospects · Overview of 2006 Results, page 30
SEC asked (3)
In your discussion of changes in revenue you identify two or more s ources of a material change, but do not disclose the dollar amounts for each source that contributed to the change. For instance, your disclosures indicate that revenues have changed period to period as a result of higher volumes of sales and the addition of new customers in Asia and lower volumes of sales in Europe.
Rest of the question

However, you do not provide quantitative disclosures regarding the impact of these items during the periods presented. Please advise why your disclosure does not quantify each source that contributed to a material change. Please see Section III. D of SEC Release 33-6835.

CLS answered

No numbered answer found in the reply. Read the reply ↗

Controls and Procedures, page 44
SEC asked (4)
Your conclusion that your disc losure controls and procedures were effective “to ensure that information required to be disclosed by us in our corporate filings is recorded, processed, summarized and reported within the required time periods” is more limited in scope than what is called for under Rule 13a-15(e) of the Exchange Act.
Rest of the question

The rule requires, among other matters, that the disclosure controls and procedures also be designed to ensure that “information required to be disclosed by an issuer . . . is accumulated and communicated to the issuer's management . . . as appropriate to allow timely decisions regarding required disclosure.” Please confirm, if true, that your disclosure controls and procedures for the relevant period met all of the requirements of Rule 13a-15(e). Additionally, tell us how you intend to comply with this requirement in your subsequent reports by including a complete statement in your controls and procedures section or, alternatively, by referring to the definition contained in Rule 13a-15(e).

CLS answered
The following paragraph from our third quarter 2007 MD&A provides an update on the Mexico situation:

We have been focused on simplifying the operations and improving the financial results in Mexico. We have transferred certain customers or programs from Mexico to our Asian manufacturing facilities and disengaged from certain other customers that were adding to the complexity of our Mexican operations.

We have completed all but one of the planned program transfers, which has been delayed at the request of the customer. In addition, several customers chose to disengage business from us.
Rest of the answer

As a result of the transfers out of Mexico, we have reduced our inventory parts complexity, consolidated the number of warehouses and reduced our headcount. We have integrated our ERP platforms and implemented new software tools to drive best practices at this site for supply chain and materials management. Operationally, we have made progress in quality, delivery and productivity in Mexico. Customer satisfaction levels have continued to improve each quarter of 2007. Mexico’s operating losses, calculated as gross profit less SG&A, for the three and nine months ended September 30,

2007 were $10 million and $48 million, respectively, compared to operating losses of $7 million and $26 million, respectively, for the same periods in

2006. Operating losses have been reduced sequentially by $11 million from the second quarter of 2007, primarily due to the progress in consolidating our warehouses and implementing process improvements. The second quarter of 2007 was burdened with higher than expected costs of disengaging with certain customers, most of which have now been settled and the transfers completed.

Operating losses have worsened compared to the prior year primarily from the impact of lower volumes, offset partially by improved efficiencies due to changes in Mexico’s infrastructure and processes. Though we expect Mexico to continue to incur operating losses for the next several quarters, Mexico remains a strategic part of our operations.

We will continue to provide this level of analysis in future filings. As to the Staff’s request to disclose the relationship between the issues at the Mexican operations and any litigation, there is only an allegation in a recently filed amended complaint that

Celestica failed to timely disclose certain matters relating to our operations in Mexico. Celestica does not believe additional disclosure is appropriate or required.

2. We note your disclosure that Cisco

Systems and IBM each accounted for 10% of your total revenues in 2006. A description of your contractual arrangements with these customers appears warranted. Also, you do not appear to have filed agreements with either customer as exhibits to your annual report. Please advise whether you are substantially dependent upon these customers for purposes of Instruction 4(b)(ii) of the Instructions as to Exhibits in Form 20-F.

RESPONSE:

In response to the Staff’s comment, Celestica does not believe that it is “substantially dependent” on any customers within the meaning of instruction 4(b)(ii). Accordingly, we have not filed the agreements with IBM or Cisco Systems as exhibits to our Form 20-F.

Celestica’s agreements with IBM and Cisco Systems are of the type that ordinarily accompanies our business. Generally, one or more “master” agreements will govern the overall relationship with a customer, or a particular division of a customer. These agreements do not usually commit a customer to specific purchases and do not guarantee any revenue to

Celestica. Rather, other agreements (or purchase orders) are entered into from time to time with respect to specific products or services. There is no single agreement (or series of related agreements) that relates to the major part of

Celestica’s products or services.

Therefore, we do not believe that the agreements with IBM and Cisco

Systems are material and have not included a description of these agreements in our Form 20-F.

Read in the reply
Item 8. Financial Information · Litigation, page 78
SEC asked (5)
We note your disclosure on page 16 of cla ss action lawsuits in which the company and current and former members of senior management are named as defendants. A discussion of these class action lawsuits would appear warranted in this section, given your discussion of these lawsuits in your Risk Factors section. Please advise.
Rest of the question

* * * * * Please respond to these comments within 10 business days or tell us when you will provide us with a response. Please submit all correspondence and supplemental materials on EDGAR as required by Rule 101 of Regulation S-T. If you amend your filing, you may wish to provide us with marked copies of any amendment to expedite our review. Please furnish a cover letter that keys your responses to our comments and provides any requested information. Detailed cover letters greatly facilitate our review. Please understand that we may have additional comments after reviewing any amendment and your responses to our comments.

CLS answered
Filing includes this statement: “Revenue for 2006 of $8.8 billion increased 4% from $8.5 billion in 2005, primarily due to higher volumes and new customers in

Asia, offset in part by lower volumes in Europe.” The impact of these items were: higher volumes in Asia accounted for a 4% increase in revenue from 2005, new customers in Asia accounted for a 3% increase in revenue from 2005 and lower volumes in Europe accounted for a 3% decrease in revenue from 2005.

will expand our internal analysis of changes in revenue in order to provide the quantitative impacts of these changes in future
Rest of the answer

filings.

4. Your conclusion that your disclosure controls and procedures were effective “to ensure that information required to be disclosed by us in our corporate filings is recorded, processed, summarized and reported within the required time periods” is more limited in scope than what is called for under Rule 13a-15(e) of the Exchange Act. The rule requires, among other matters, that the disclosure controls and procedures also be designed to ensure that “information required to be disclosed by an issuer...is accumulated and communicated to the issuer’s management...as appropriate to allow timely decisions regarding required disclosure.” Please confirm, if true, that your disclosure controls and procedures for the relevant period met all of the requirements of Rule 13a-15(e).

Additionally, tell us how you intend to comply with this requirement in your subsequent reports by including a complete statement in your controls and procedures section or, alternatively, by referring to the definition contained in Rule 13a-15(e).

RESPONSE:

Celestica’s Filing included this statement: “The Chief Executive Officer and Chief Financial Officer have evaluated our disclosure controls and procedures as of the end of the year, and have concluded that such controls and procedures are effective to ensure that information required to be disclosed by us in our corporate filings is recorded, processed, summarized and reported within the required time periods.”

Celestica recognizes that our disclosure controls and procedures must meet all of the requirements of Rule 13a-15(e) and we hereby confirm that our disclosure controls and procedures for the relevant time period met all of the requirements of the rule. We will expand our disclosure on controls and procedures in future filings to read as follows:

Our management is responsible for establishing and maintaining a system of disclosure controls and procedures (as defined in Rule 13a-15 and 15d-15 under the Securities

Exchange Act of 1934 (the “Exchange Act”)) designed to ensure that information we are required to disclose in the reports that we file or submit under the

Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive officer or officers and principal financial officer or officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

We have evaluated the effectiveness of the design and operation of our disclosure controls and procedures under the supervision of and with the participation of management, including the Chief Executive Officer and Chief Financial Officer, as of the end of the period covered by this report. Based on that evaluation, our Chief

Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in our corporate filings is recorded, processed, summarized and reported within the required time periods.

8. FINANCIAL INFORMATION

5. We note your disclosure on page 16 of class action lawsuits in which the company and current and former members of senior management are named as defendants. A discussion of these class action lawsuits would appear warranted in this section, given your discussion of these lawsuits in your Risk Factors

Section. Please advise.

RESPONSE:

A cross reference to the class action lawsuit disclosure in Item 5., Operating and Financial Review and Prospects, will be included in future filings where appropriate.

* * * do not believe that the information we have provided in this response to the

Staff’s comments materially changes the information we have provided previously in the Filing. As described above,

Celestica’s third quarter 2007 MD&A has provided current information on our

Mexico operations, and we have undertaken to provide certain other information in future filings.

As requested by the Commission, Celestica hereby acknowledges the following:

· we are responsible for the adequacy and accuracy of the disclosure in its filings;

· Staff comments or changes to disclosure in response to Staff comments do not foreclose the Commission from taking any action with respect to the filing; and

· the Company may not assert Staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Read in the reply
Item 4. Information on the Company · Celestica’s Focus, page 19
SEC asked (1)
We refer to comment 1 of our letter dated November 30, 2007. In that comment, we asked you to consider discussing the relationship between the problems at the Mexican facility and the class action lawsuit you disclose on page 42 of your Form 20-F. In response, you state that there is only an allegation in a complaint that you failed to timely disclose certain matters relating to your operations in Mexico.
Rest of the question

You then conclude, without any analysis, that you do not believe additional disclosure is appropriate or required. Please tell us why you do not believe additional disclosure is appropriate or required in this circumstance. See Item 8.A.7 of Form 20-F.

CLS answered

No numbered answer found in the reply. Read the reply ↗

Controls and Procedures, page 44
SEC asked (2)
We refer to comment 4 of our letter dated November 30, 2007. In your response to that comment, you have included two paragraphs of proposed revised disclosure regarding disclosure controls and procedures. Refer to the last sentence of the second paragraph.
Rest of the question

Your proposed language regarding the effectiveness conclusion appearing in that sentence remains limited to only the first part of the definition of disclosure controls and procedures. You should either include the entire definition in your effectiveness conclusion, or simply cite to disclosure controls and procedures as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934. * * * * * Please respond to these comments within 10 business days or tell us when you will provide us with a response. Please submit all correspondence and supplemental materials on EDGAR as required by Rule 101 of Regulation S-T. If you amend your filing, you may wish to provide us with marked copies of any amendment to expedite our review. Please furnish a cover letter that keys your responses to our comments and provides any requested information. Detailed cover letters greatly facilitate our review. Please understand that we may have additional comments after reviewing any amendment and your responses to our comments.

CLS answered

No numbered answer found in the reply. Read the reply ↗

Also in this review: request for more time, Dec 5, 2007, closing letter, 2008-01-16

Letters without questions

Other letters

UPLOAD and CORRESP
1 other letter: notices that a filing will not be reviewed, requests to declare a registration effective, and the like
  • Dec 31, 2015 · CLS: letter to the SEC · Celestica Inc. (the “Company”) · Form 20-F for the Fiscal Year Ended December 31, 2015...

From the SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), 28 letters filed since 2007-11-30. Questions and answers are matched by their numbers; topics come from words in each question. The reports are compared word for word (same form, before the first SEC letter against the first report after the company's reply). No AI.

Sources

The SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), matched question by question. No AI.

Also

Filings: the letters in the filing list.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CLS/export.csv") into a cell.

Next in Owners and insiders:Insider trades
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.